Clinical Trial Update: SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data

View source ↗

Summary

The SPRING study evaluates real-world clinical care pathways for people with type 2 diabetes mellitus and chronic kidney disease across four European countries;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD) | Status: COMPLETED